[{"Assets_0_Q3_USD":2374301000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":202399000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":212610000.0,"StockholdersEquity_0_Q3_USD":1757750000.0,"RevenuesConverted_3_Q3_USD":1092060000.0,"RevenuesConverted_1_Q3_USD":381534000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":206796000.0,"NetIncomeLossConverted_3_Q3_USD":-163513000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-3721000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.81,"EarningsPerShareDiluted_1_Q3_USD":0.17,"EarningsPerShareBasic_3_Q3_USD":-0.81,"EarningsPerShareBasic_1_Q3_USD":0.17,"CommonStockSharesOutstanding_0_Q3_shares":211019366.0,"CommonStockSharesConverted_0_Q3_shares":211019366.0,"NetIncomeLossConverted_1_Q3_USD":36054000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":202399000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20171031"}]